Food supplements based on palmitoylethanolamide plus hydroxytyrosol from olive tree or Bacopa monnieri extracts for neurological diseases
ReviewHumansOther animalsWith hydroxytyrosol (olive extract) and Bacopa monnieri extract, discussed as supplement partners
This study tested palmitoylethanolamide together with hydroxytyrosol (olive extract) and Bacopa monnieri extract, discussed as supplement partners. Its results cannot be assigned to palmitoylethanolamide alone. More combination studies.
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- What palmitoylethanolamide, hydroxytyrosol and Bacopa monnieri extracts offer against neuroinflammation and neurodegeneration: a review covering Parkinson disease, Alzheimer disease, spinal cord injury and stroke
What the authors reported
The three compounds share reported neuroprotective actions against shared features of neurodegenerative disease, the authors say, including protein aggregation, oxidative stress, apoptosis, excitotoxicity, calcium imbalance and inflammation. The abstract gives no numbers and no trial data.
Limits of this study
A narrative review, not a trial; it reports the authors' reading of the literature. The abstract gives no search method or study selection. The authors declare no commercial associations.
Source
PubMed 33170159 · doi:10.23750/abm.v91i13-S.10582
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.